News
INB-619 precisely targets and eliminates B cells from lupus patient samples, including harmful IgG1 and IgM antibodies, ...
Zacks Small Cap Research on MSN4h
IMNN: First Site Activated for Phase 3 OVATION 3 Trial…IMNN READ THE FULL IMNN RESEARCH REPORT Business Update First Site Activated for Phase 3 OVATION 3 Trial of IMNN-001 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback